Bionomics Limited Stock Profit Margin
Bionomics Limited fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Pink Sheet. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics pink sheet.
Bionomics |
Bionomics Limited Company Profit Margin Analysis
Bionomics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Bionomics Limited has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
Bionomics Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.18 | |||
Operating Margin | (2.91) % | |||
Current Valuation | 27.83 M | |||
Shares Outstanding | 1.35 B | |||
Shares Owned By Insiders | 6.00 % | |||
Shares Owned By Institutions | 48.96 % | |||
Price To Earning | (34.09) X | |||
Price To Book | 1.24 X | |||
Price To Sales | 8.29 X | |||
Revenue | 263.63 K | |||
Gross Profit | (9.94 M) | |||
EBITDA | (21.92 M) | |||
Net Income | (21.76 M) | |||
Cash And Equivalents | 33.56 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 693.62 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 12.46 X | |||
Book Value Per Share | 0.04 X | |||
Cash Flow From Operations | (21.76 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 22 | |||
Beta | 2.18 | |||
Market Capitalization | 29.11 M | |||
Total Asset | 65.31 M | |||
Retained Earnings | (103 M) | |||
Working Capital | 47 M | |||
Current Asset | 58 M | |||
Current Liabilities | 11 M | |||
Z Score | 23.2 | |||
Net Asset | 65.31 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |